AA
BIIB icon

Apriem Advisors’s Biogen BIIB Stock Holding History

Apriem Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,699
Closed -$346K – 143
2022
Q2 		$346K Sell
1,699
-408
-19% -$83.4K 0.06% 107
2022
Q1 		$444K Sell
2,107
-822
-28% -$179K 0.07% 101
2021
Q4 		$703K Sell
2,929
-33
-1% -$8.48K 0.1% 75
2021
Q3 		$838K Sell
2,962
-21,791
-88% -$7.14M 0.12% 71
2021
Q2 		$8.57M Sell
24,753
-36,409
-60% -$11M 1.28% 23
2021
Q1 		$17.1M Buy
61,162
+8,172
+15% +$2.2M 2.65% 12
2020
Q4 		$13M Sell
52,990
-3,297
-6% -$851K 2.31% 16
2020
Q3 		$16M Buy
56,287
+791
+1% +$221K 2.93% 9
2020
Q2 		$14.8M Buy
55,496
+2,274
+4% +$684K 3.05% 8
2020
Q1 		$16.8M Buy
53,222
+106
+0.2% +$32.2K 4.08% 4
2019
Q4 		$15.8M Buy
53,116
+3,233
+6% +$897K 3.02% 5
2019
Q3 		$11.6M Buy
49,883
+47,363
+1,879% +$11M 2.57% 7
2019
Q2 		$589K Buy
+2,520
New +$582K 0.18% 74
2018
Q3 		– Sell
-42
Closed -$12K – 169
2018
Q2 		$12K Buy
+42
New +$11.8K ﹤0.01% 398
2017
Q2 		– Sell
-42
Closed -$11K – 182
2017
Q1 		$11K Hold
42
– – ﹤0.01% 407
2016
Q4 		$12K Buy
42
+17
+68% +$5.04K ﹤0.01% 422
2016
Q3 		$8K Sell
25
-156
-86% -$46.2K ﹤0.01% 418
2016
Q2 		$44K Buy
181
+6
+3% +$1.58K 0.01% 240
2016
Q1 		$46K Hold
175
– – 0.02% 211
2015
Q4 		$54K Hold
175
– – 0.02% 195
2015
Q3 		$51K Buy
175
+150
+600% +$49.5K 0.02% 200
2015
Q2 		$10K Hold
25
– – ﹤0.01% 412
2015
Q1 		$11K Hold
25
– – ﹤0.01% 399
2014
Q4 		$8K Buy
+25
New +$8.09K ﹤0.01% 387

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Apriem Advisors's BIIB Position: Q3 2022 in Review

Apriem Advisors sold out of Biogen (BIIB) in Q3 2022, closing a stake of 1,699 shares — an estimated $346K sold.

Apriem Advisors first reported a position in BIIB in Q4 2014 and held it in 24 quarters. The position peaked at $17.1M in Q1 2021. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Apriem Advisors reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • Apriem Advisors sold 1,699 Biogen shares in Q3 2022, an estimated $346K.
  • Apriem Advisors first reported a position in Biogen in Q4 2014 and held it in 24 quarters.
  • Apriem Advisors's Biogen position peaked at $17.1M in Q1 2021.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Apriem Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.